Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05127707 · ClinicalTrials.gov registry record · NA
Strategies to Reduce Addiction Stigma Among Health Professionals
A NA study, sponsored by Johns Hopkins Bloomberg School of Public Health.
- Completed
- Registry status
- NA
- Development phase
- 1,842
- Enrollment target
NCT05127707: Completed NA study, sponsored by Johns Hopkins Bloomberg School of Public Health.
NCT05127707 is a NA study that has completed, run by Johns Hopkins Bloomberg School of Public Health. The registered enrollment target is 1,842 participants, above the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (31% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05127707, a NA study, has completed, sponsored by Johns Hopkins Bloomberg School of Public Health.
- COMPLETED
- Registry status
- NA
- Development phase
- 1,842 participants
- Enrollment target
Study Summary
The aim of this study was to evaluate the effects of exposure to stigma reduction message frames communicated by visual campaigns and narrative vignettes among a national sample of health professionals.
Primary Outcome
Item from the Social Distance Scale that measures one element of stigma (desire for social distance). Measured on 5-point Likert scale with 5 indicating greater unwillingness and 1 indicating greater willingness to have a person with opioid use disorder marry into the family. Measured via survey questionnaire.
Interventions
- BEHAVIORAL Words Matter - Visual Campaign
- BEHAVIORAL Words Matter - Visual Campaign & Narrative Vignette (Messenger: Person with Opioid Use Disorder) Experimental: Words Matter - Visual Campaign & Narrative Vignette (Messenger: Clinician)
- BEHAVIORAL Words Matter - Visual Campaign & Narrative Vignette (Messenger: Clinician)
- BEHAVIORAL Words Matter - Visual Campaign & Narrative Vignette (Messenger: Health System Administrator)
- BEHAVIORAL Medication Treatment for Opioid Use Disorder Works - Visual Campaign
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,842 participants |
| Start Date | 2020-11-13 |
| Est. Completion | 2020-11-30 |
| Phase | NA |
What the finished NCT05127707 record still lists
NCT05127707 is an interventional study that assigns participants to a tested intervention. Its 1,842 participants enrollment target places it among the larger protocols in the corpus, above the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (31% higher).
The record links to 0 conditions, and to 5 interventions - of which Words Matter - Visual Campaign is the first listed.
NCT05127707 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05127707 about?
NCT05127707 is a clinical study titled "Strategies to Reduce Addiction Stigma Among Health Professionals". The aim of this study was to evaluate the effects of exposure to stigma reduction message frames communicated by visual campaigns and narrative vignettes among a national sample of health professionals.
What is the current status of trial NCT05127707?
This trial is currently completed. It is a NA study. The enrollment target is 1,842 participants. The study started on 2020-11-13. Estimated completion is 2020-11-30.
What interventions are being tested in trial NCT05127707?
The interventions under investigation include: Words Matter - Visual Campaign (BEHAVIORAL), Words Matter - Visual Campaign & Narrative Vignette (Messenger: Person with Opioid Use Disorder) Experimental: Words Matter - Visual Campaign & Narrative Vignette (Messenger: Clinician) (BEHAVIORAL), Words Matter - Visual Campaign & Narrative Vignette (Messenger: Clinician) (BEHAVIORAL), Words Matter - Visual Campaign & Narrative Vignette (Messenger: Health System Administrator) (BEHAVIORAL), Medication Treatment for Opioid Use Disorder Works - Visual Campaign (BEHAVIORAL).
Who is sponsoring clinical trial NCT05127707?
This trial is sponsored by Johns Hopkins Bloomberg School of Public Health, which has 187 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT05127707's enrollment target sits among peer trials
1,842 57th of 2000 higher than 1,944 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06740630 · 1,840 participants · Phase 3
A Study on the Immune Response and Safety of an Investigational Chickenpox Vaccine When Given to Healthy Children 12 to 15 Months of Age
- NCT07104240 · 1,836 participants · NA
A Vaccine Promotion Package (TweenVax) to Improve Adolescent HPV Vaccination, TweenVax Trial
- NCT06465810 · 1,850 participants
Non-interventional Study of Patients With Transthyretin (ATTR) Amyloidosis
- NCT06580080 · 1,850 participants · NA
Evaluation of Are You Ready?
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI